Drug details

Viibryd (vilazodone hydrochloride)

type of Antidepressants, SSRI/5HT-1A Partial Agonist

Viibryd (vilazodone hydrochloride) is a selective serotonin reuptake inhibitor (SSRI) type antidepressant used to treat major depressive disorder in adults.

This drug may have the following side effects:

• nausea,
• diarrhea,
• sleep problems (insomnia).
• vomiting, and

The following drugs are related to Viibryd, either as a replacement or used together:

• Albuterol Sulfate Tablets (albuterol sulfate tablets)
• Auvelity (dextromethorphan hydrobromide, bupropion hydrochloride)
• Zyban (bupropion hcl)
• Wellbutrin (bupropion hcl)
• Wellbutrin XL (bupropion hydrochloride extended-release)
• Wellbutrin SR (bupropion hydrochloride sustained-release)
• Celexa (citalopram hydrobromide)
• Drizalma Sprinkle (duloxetine delayed-release capsules)
• Irenka (duloxetine capsules)
• Effexor (venlafaxine hydrochloride)
• Effexor XR (venlafaxine hydrochloride extended-release)
• Lexapro (escitalopram oxalate)
• Spravato (esketamine nasal spray)
• Paxil (paroxetine hydrochloride)
• Paxil-CR (paroxetine hydrochloride)
• Venbysi XR (venlafaxine extended-release tablets)